Neurocentrx Pharma

Helping develop a safer ketamine capsule for depression

We aim for the first FDA-approved oral ketamine for severe depression, safe enough for care at home.

Talk to me about
NeoPhore

Helped launch a cancer immunotherapy spinout

NeoPhore grew from our founders' Nature-published work using DNA repair inhibition to boost cancer immunity.

Talk to me about
COO at PhoreMost·2015 – 2018

Ran operations at PhoreMost as COO for three years

PhoreMost used Protein Interference screening to unmask hidden druggable sites across the human genome.

Talk to me about
CEO at NeoPhore·2018 – 2020

Became CEO of NeoPhore, the PhoreMost spinout

I led NeoPhore's push to build small-molecule drugs that spark cancer neoantigens for immunotherapy.

Talk to me about
Volunteer at UK Biocentre·2020 – 2021

Volunteered in the UK Lighthouse COVID testing labs

During the pandemic I volunteered at UK Biocentre's Lighthouse labs for about ten months.

Talk to me about
Jeff Roix

Jeff Roix⁠

About

I'm CEO of Neurocentrx Pharma, a biotech developing oral ketamine treatments.

Experiences

  1. Neurocentrx PharmaHelping develop a safer ketamine capsule for depression

    We aim for the first FDA-approved oral ketamine for severe depression, safe enough for care at home.

  2. NeoPhoreHelped launch a cancer immunotherapy spinout

    NeoPhore grew from our founders' Nature-published work using DNA repair inhibition to boost cancer immunity.

  3. COO at PhoreMostRan operations at PhoreMost as COO for three years

    PhoreMost used Protein Interference screening to unmask hidden druggable sites across the human genome.

  4. CEO at NeoPhoreBecame CEO of NeoPhore, the PhoreMost spinout

    I led NeoPhore's push to build small-molecule drugs that spark cancer neoantigens for immunotherapy.

  5. Volunteer at UK BiocentreVolunteered in the UK Lighthouse COVID testing labs

    During the pandemic I volunteered at UK Biocentre's Lighthouse labs for about ten months.

Follow Jeff for more...

LinkedIn

© 2026 Delphi · Terms · Privacy

Jeff Roix

Jeff Roix⁠

About

I'm CEO of Neurocentrx Pharma, a biotech developing oral ketamine treatments.

Experiences

  1. Neurocentrx PharmaHelping develop a safer ketamine capsule for depression

    We aim for the first FDA-approved oral ketamine for severe depression, safe enough for care at home.

  2. NeoPhoreHelped launch a cancer immunotherapy spinout

    NeoPhore grew from our founders' Nature-published work using DNA repair inhibition to boost cancer immunity.

  3. COO at PhoreMostRan operations at PhoreMost as COO for three years

    PhoreMost used Protein Interference screening to unmask hidden druggable sites across the human genome.

  4. CEO at NeoPhoreBecame CEO of NeoPhore, the PhoreMost spinout

    I led NeoPhore's push to build small-molecule drugs that spark cancer neoantigens for immunotherapy.

  5. Volunteer at UK BiocentreVolunteered in the UK Lighthouse COVID testing labs

    During the pandemic I volunteered at UK Biocentre's Lighthouse labs for about ten months.

Follow Jeff for more...

LinkedIn

© 2026 Delphi · Terms · Privacy

By using this service, you agree to the Terms of Service and Privacy Policy.